Joseph C. Cappelleri

Articles by Joseph C. Cappelleri

28 Enhancing the Interpretation of Real-World Quality of Life (QoL) in Patients With Hormone Receptor– Positive/Human Epidermal Growth Factor Receptor 2–Negative (HR+/HER2-) Advanced Breast Cancer (ABC) Enrolled in the POLARIS Trial

28 Enhancing the Interpretation of Real-World Quality of Life (QoL) in Patients With Hormone Receptor– Positive/Human Epidermal Growth Factor Receptor 2–Negative (HR+/HER2-) Advanced Breast Cancer (ABC) Enrolled in the POLARIS Trial

ByGabrielle Rocque,Joanne L. Blum, MD, PhD,Yan Ji,Eric Gauthier,Yao Wang,Monica Z. Montelongo,Joseph C. Cappelleri,Connie Chen,Meghan S. Karuturi,Debu Tripathy, MD

July 24th 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Tucatinib Combo as Maintenance in HER2+ Breast Cancer

Novel Cancer Vaccine Plus Temozolomide Miss Primary End Point in Glioblastoma

FDA Approves Atezolizumab/Chemo for Stage III dMMR Colon Cancer

Personalized Vaccines May Have Utility Across All Lung Cancer Stages

Considering Talquetamab and Emerging Bispecifics in R/R Multiple Myeloma